NRC Health Q3 2025: TRCV up 8% to $141.7M; Adj EBITDA +11% YoY to $10.9M

NRC HEALTH

2025-Q3 EPS reported $0.43 revenue$102,196,000

Revenue $34.6M (+2% QoQ); GAAP net income $4.1M (12% of revenue); Adj net income $5.0M (14% of revenue).
GAAP EPS $0.18; adjusted EPS $0.23 on 22.1M diluted shares.
Cash from operations $13.8M (+46% YoY), representing 40% of total revenue.
Total Recurring Contract Value (TRCV) $141.7M, up 8% YoY; fourth consecutive quarterly growth.
CEO Trent Green cited strong sales and improved customer retention as growth drivers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.